Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Date:9/14/2007

e at http://www.palatin.com.

Forward-looking Statements

Statements about the Company's future expectations, including statements about its development programs, proposed indications for its product candidates, pre-clinical activities, marketing collaborations, and all other statements in this document other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements shall be subject to the safe harbors created thereby. Palatin's actual results may differ materially from those discussed in the forward-looking statements for various reasons, including, but not limited to the Company's ability to fund development of its technology, ability to establish and successfully complete clinical trials and pre-clinical studies and the results of those trials and studies, dependence on its partners for certain development activities, need for regulatory approvals and commercial acceptance of its products, ability to recommence marketing and gain commercial acceptance of NeutroSpec(R), ability to protect its intellectual property, and other factors discussed in the Company's periodic filings with the Securities and Exchange Commission. The Company is not responsible for updating for events that occur after the date of this press release.

PALATIN TECHNOLOGIES, INC.

Consolidated Statement of Operations Data

Year Ended June 30,

2007 2006 2005

REVENUES:

Licenses, grants and contracts $14,405,665 $18,239,783 $13,896,818

Royalties - 1,508,862 1,58
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... of a meter in size, are around us every ... health, as in some innovative early cancer treatments, but ... pollution, traffic emissions, cosmetics, sunscreen and electronics. , A ... led by Lan Yang, PhD, the Das Family Career ... their collaborators at Tsinghua University in China have developed ...
(Date:9/2/2014)... Sept. 2, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... approach for protecting personal data in Clinical Study ... and others. The document describes an approach to ... CSRs and other related clinical trial documents, and ... goal of the TransCelerate CSR Redaction approach is ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Xencor, ... biopharmaceutical company developing engineered monoclonal antibodies for the ... and cancer, today announced the appointment of ... development and the appointment of Lloyd Rowland ... general counsel. "Debra,s expertise in ...
(Date:9/2/2014)... Md. , Sept. 2, 2014  Spherix Incorporated ... and monetization of intellectual property, today announced that the ... patents to the Company in the month of August ... patents.  The issued patents are: ... , U.S.RE45,081 issued August 19, 2014; and , ...
Breaking Biology Technology:Engineers develop new sensor to detect tiny individual nanoparticles 2Engineers develop new sensor to detect tiny individual nanoparticles 3TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 3Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2
... connecting bones to muscles that raise an eyebrow or propel ... unusually forceful or awkward pull on the strings leaves us ... repair over 300,000 of these injuries every year, and doctors ... Using a combination of nanoscience and biomedical and civil engineering ...
... long a standard tool in biomedical research and diagnostic ... to new electronic biosensing technology developed by a team ... Institute of Technology. Essentially arrays of tiny test ... test multiple samples for their responses to chemicals, living ...
... Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today ... has denied Ramius, legitimate request for a list of the ... has launched a tender offer to purchase all of the ... in cash.  Ramius requested the stockholder list materials in accordance ...
Cached Biology Technology:The Achilles' heel of tendons 2The Achilles' heel of tendons 3Novel electronic biosensing technology could facilitate new era of personalized medicine 2Novel electronic biosensing technology could facilitate new era of personalized medicine 3Novel electronic biosensing technology could facilitate new era of personalized medicine 4Cypress Denies Ramius' Legal Right to Stockholder List Materials 2Cypress Denies Ramius' Legal Right to Stockholder List Materials 3
(Date:9/2/2014)... Museum will present the prestigious Parker/Gentry Award to Mr. ... biodiversity conservation awareness. The Parker/Gentry Award is given annually ... or organization whose efforts have had a significant impact ... actions can serve as a model to others. , ... science and conservation news website that draws more than ...
(Date:9/2/2014)... BETHESDA, MD The American Society of Human ... Institute (NHGRI), part of the National Institutes of ... School Science Teacher at The Wellington School in ... Fellow. The 16-month appointment begins today. , The ... early-career genetics professionals expand their skills, experience, and ...
(Date:9/2/2014)... It,s not always true that digital distribution of ... by physical means, at least when file sizes ... study published in Yale,s Journal of Industrial ... of games for consoles such as PlayStation3. Researchers ... caused lower greenhouse gas emissions than game files ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2
... (NREL) is working with Ecopetrol, the largest oil company ... and palm oil harvesting into fuel ethanol for blending ... (CRADA) between NREL and Ecopetrol aims to optimize the ... the sugars are removed from the sugar cane) and ...
... WASHINGTON D.C. August 13, 2013 -- Adjacent to the walls of ... up our microcirculation -- there exists a peculiar thin layer of ... a few millionths of a meter thick, that layer is vital. ... the site of a cut and start the clotting process. ...
... brightly coloured crowns are better mothers than duller birds, according ... , Unlike humans, birds can see ultra-violet (UV) light. While ... us, to another bird it has the added dimension of ... also involved researchers from the University of California Davis, USA ...
Cached Biology News:NREL and Colombian oil firm unlocking agricultural waste feedstocks for biofuel 2NREL and Colombian oil firm unlocking agricultural waste feedstocks for biofuel 3Computer model predicts red blood cell flow 2Bright birds make good mothers 2
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
... series of refrigerated cold traps offers a ... low volatility/aqueous solvents or high volatility solvents. ... vacuum concentrators/centrifugal evaporators. Also used for maintaining ... as used in electron microscopes. Can be ...
Black 96 Well Plate EB, RE Bottom...
Biology Products: